Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

½ºÅÙÆ®¸¦ ÀÌ¿ëÇÑ ¸¸¼º ±Ë¾ç¼º Ä¡Àº º´¼ÒÀÇ ±¹¼Ò ½ºÅ×·ÎÀ̵å Ä¡·á

Topical Steroid Therapy using Stent on Chronic Ulcerative Gingival Lesions

´ëÇѱ¸°­³»°úÇÐȸÁö 2010³â 35±Ç 4È£ p.259 ~ 264
¹ÚÇü¿í, ¾ÈÇüÁØ, ÃÖÁ¾ÈÆ, ±ÇÁ¤½Â,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÇü¿í ( Park Hyung-Wook ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
¾ÈÇüÁØ ( Ahn Hyung-Joon ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
ÃÖÁ¾ÈÆ ( Choi Jong-Hoon ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
±ÇÁ¤½Â ( Kwon Jeong-Seung ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç

Abstract

¸¸¼º ±Ë¾ç¼º Ä¡Àº º´¼Ò´Â ÆíÆòż±, ¾ç¼ºÁ¡¸·À¯ÃµÆ÷â, ½É»ó¼º õÆ÷â µî°ú °°Àº ´Ù¾çÇÑ Áúȯ¿¡ ÀÇÇØ À¯¹ßµÉ ¼ö ÀÖÀ¸¸ç ÄÚƼÄÚ½ºÅ×·ÎÀÌµå ¾à¹°¿ä¹ýÀÌ ÁÖµÈ Ä¡·á·Î ÀÌ¿ëµÈ´Ù. ÄÚƼÄÚ½ºÅ×·ÎÀ̵带 º¹¿ëÇÏ´Â °æ¿ì À§ÀåÀå¾Ö, üÁßÁõ°¡ µîÀÇ ºÎÀÛ¿ë »Ó¸¸ ¾Æ´Ï¶ó Àå±â º¹¿ë ½Ã °ñ´Ù°øÁõ, ´ç´¢ ¹× °íÇ÷¾Ð ¹ß»ý ¶Ç´Â ¾ÇÈ­, ºÎ½Å±â´É ÀúÇÏ, Äí½ÌÁõÈıº µîÀÇ ½É°¢ÇÑ ºÎÀÛ¿ëÀÌ ¹ß»ýÇÒ ¼ö ÀÖ¾î º´¼Ò°¡ ±¹¼Ò ºÎÀ§¿¡ Á¦ÇÑµÇ¾î ¹ß»ýÇϰųª Àü½ÅÁõ»óÀ» µ¿¹ÝÇÏÁö ¾Ê´Â °æ¿ì ½ºÅ×·ÎÀÌµå ¾à¹°ÀÇ ±¹¼Ò µµÆ÷°¡ ¸¸¼º ±Ë¾ç¼º Ä¡Àº º´¼ÒÀÇ ÁÖµÈ Ä¡·á·Î ÀÌ¿ëµÇ°í ÀÖ´Ù.
ÇÏÁö¸¸ ±¹¼Ò ½ºÅ×·ÎÀ̵å Ä¡·á¸¦ ±¸°­ ³»¿¡ »ç¿ëÇÏ´Â °æ¿ì Ÿ¾× ºÐºñ, Çô, ÀÔ¼ú, ÇùÁ¡¸· µîÀÇ ¿òÁ÷ÀÓ¿¡ ÀÇÇØ µµÆ÷ÇÑ ¾àÁ¦°¡ ¼Ò½ÇµÇ¾î È¿°ú°¡ °¨¼ÒµÇ°í º´¼Ò°¡ ³ÐÀº ºÎÀ§¿¡ ºÐÆ÷Çϰųª ±¸°­ ³» ±í¼÷ÇÑ ºÎÀ§¿¡ ¹ß»ýÇÏ´Â °æ¿ì ȯÀÚ ½º½º·Î ¾à¹°À» µµÆ÷ÇϱⰡ ¿ëÀÌÇÏÁö ¾ÊÀ¸¸ç, Áúº´¿¡ ÀÌȯ µÇÁö ¾ÊÀº Á¤»ó Á¡¸·¿¡µµ ¾àÁ¦°¡ µµÆ÷ µÇ´Â µîÀÇ ´ÜÁ¡ÀÌ ÀÖ´Ù.
±¹¼Ò ½ºÅ×·ÎÀ̵å Àû¿ë ¹æ¹ýÀÇ ´ÜÁ¡À» ±Øº¹ÇÏ°í È¿°ú¸¦ ÃÖ´ëÈ­ÇÔÀ¸·Î½á ½ºÅ×·ÎÀÌµå º¹¿ëÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ¸·Î ½ºÅÙÆ®¸¦ ÀÌ¿ëÇÑ ½ºÅ×·ÎÀÌµå ¹ÐÆó ¿ä¹ýÀÌ º¸°íµÈ ¹Ù ÀÖÀ¸³ª ½ÇÁ¦ ÀÓ»ó¿¡¼­ Àû±ØÀûÀ¸·Î È°¿ëµÇÁö´Â ¾Ê°í ÀÖ´Ù. µû¶ó¼­ ¸¸¼º ±Ë¾ç¼º Ä¡Àº º´¼Ò°¡ ¹ß»ýÇÑ È¯ÀÚ¿¡°Ô ½ºÅÙÆ®¸¦ ÀÌ¿ëÇÑ ±¹¼Ò½ºÅ×·ÎÀ̵å Ä¡·á¸¦ ½ÃÇàÇÏ¿© ¾çÈ£ÇÑ Ä¡·á È¿°ú¸¦ º¸ÀÎ Áõ·Ê¸¦ ÅëÇØ ±× È¿¿ë¼º°ú ÀÓ»óÀû È°¿ë ¹æ¾ÈÀ» ¾Ë¾Æº¸°íÀÚ ÇÑ´Ù.

The majority of chronic gingival ulcerative lesions are known to be due to autoimmune disease such as oral lichen planus, benign mucous membrane pemphigoid or pemphigus vulgaris. Topical or systemic corticosteroids are mainly used and adjuvant drugs like immunosuppressant, anti-inflammatory drugs, antimalarials or antimetabolites can also be prescribed. Because systemic corticosteroids causes various side effects, such as gastrointestinal disturbance, osteoporosis, diabetes or adrenal suppression.
So, topical steroid therapy is main treatment for chronic gingival ulcerative lesion confined to small area. However, there"s also limitation of topical corticosteroids. The effect of the corticosteroids decreases due to salivary flow and the movement of the tongue, lips, or buccal mucosa. When the lesions are widely distributed or positioned deeply in oral cavity, it is hard to apply the medication on patients" own. Moreover, it can be applied to unaffected mucosa.
Although occlusive steroid therapy using stent was reported to minimize taking steroid and overcome the faults of applying topical steroids, it has been used less frequently in the clinical field. Therefore, this report is going to find out the usefulness and the way to utilize clinically through the case which acted satisfactorily by performing topical steroid therapy using stent on chronic ulcerative gingival lesions.

Å°¿öµå

¸¸¼º ±Ë¾ç¼º Ä¡Àº º´¼Ò; ½ºÅÙÆ®; ±¹¼Ò ½ºÅ×·ÎÀ̵å
Chronic ulcerative gingival lesion; Stent; Topical steroid

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI